Pre-earnings options volume in Edwards Lifesciences is 1.7x normal with calls leading puts 7:5. Implied volatility suggests the market is anticipating a move near 5.3%, or $4.04, after results are released. Median move over the past eight quarters is 5.9%.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on EW:
- EDWARDS LIFESCIENCES REPORTS FOURTH QUARTER RESULTS
- Edwards Lifesciences downgraded to Underperform from Outperform at Bernstein
- Edwards Lifesciences downgraded to Neutral from Overweight at Piper Sandler
- Edwards Lifesciences not reaffirming Q4, 2023 guidance
- Edwards Lifesciences price target lowered to $73 from $78 at Canaccord